Sanitizing solution in pharma preparation flow: check stock CoA, calculate V1 = C2 x V2 / C1, dilute, sterile-filter for Grade A and B, label and record, use within the in-use period

SOP for Preparation of Sanitizing Solution in Pharma: 7 Dilutions

Short answer

A sanitizing solution is a disinfectant concentrate diluted to a fixed, validated in-use strength. A common error in published SOPs is writing the dilution as a volume of stock without stating the stock’s strength. Forty millilitres of hydrogen peroxide per litre gives 1.2 % w/v from a 30 % stock and 0.24 % from a 6 % stock, not the 4 % the label promises.

Sanitizing solution in pharma is therefore prepared in five controlled steps: read the strength from the supplier’s CoA, calculate the stock volume with V1 = C2 × V2 ÷ C1, dilute in a pre-cleaned container, make it sterile before use in Grade A and B areas, and label it with a use-by time. Revised Schedule M Part II adds that a plant must use more than one type of disinfectant, include a sporicidal agent and monitor its dilutions for microbial contamination.

What changed from the earlier version of this SOP

  • Stock strength is now part of every dilution. The earlier version gave volumes such as “40 ml hydrogen peroxide to 1 litre” without saying what strength of peroxide. Those volumes only produce the stated percentage if the stock is 100 %, which no supplied peroxide is.
  • Benzalkonium chloride: it is usually supplied as a concentrate of about 50 %, so 20 mL per litre gives about 1 %, not 2 %. Check your CoA.
  • “Glyceraldehyde” corrected to glutaraldehyde. Glyceraldehyde is a simple sugar, not a disinfectant. Glutaraldehyde is only sporicidal after it has been activated (made alkaline).
  • Phenol is now weighed, not measured. 50 mL of melted phenol is not 50 g, because melted phenol is denser than water.
  • Grade A and B sterility, labelling, use-by time and a sporicide have been added, because Revised Schedule M Part II requires them.

SOP for Preparation of Sanitizing Solution

The document below is written so a QA department can lift it into its own format. Header fields are deliberately left blank: a document number belongs to your quality management system, not to a website.

SOP No.: PRD/___/___ Version: 01 Effective: DD-MMM-YYYY Review: DD-MMM-YYYY Department: Production / QA Supersedes: ___
Standard Operating Procedure: Preparation of Sanitizing (Disinfectant) Solutions

1. Purpose

To lay down the procedure for preparing, labelling, storing and discarding sanitizing and disinfectant solutions so that each solution is used at its validated strength and within its validated in-use period.

2. Scope

Applies to all disinfectant and sanitizing solutions prepared in-house for cleaning and disinfection of production, packing, warehouse and laboratory areas, including Grade A and B areas of sterile manufacturing where applicable.

Excludes: fumigation and vapour-phase decontamination (covered by the fumigation SOP), hand antiseptics used at personnel entry, cleaning agents used for equipment cleaning validation, and ready-to-use sterile disinfectants used straight from a qualified supplier’s container (these follow the receipt and use SOP).

3. Responsibility and accountability

  • Operator, Production: prepares the solution, labels it and records the preparation.
  • Officer / Executive, Production: checks the calculation, the label and the record before the solution is released for use.
  • Microbiologist, Quality Control: monitors prepared dilutions and the areas they are used in, and runs disinfectant efficacy studies.
  • Head, Quality Assurance: approves this SOP, the disinfectant list and schedule, and the in-use periods.
  • Accountability: Head, Production.

4. Materials and equipment

  • Approved disinfectant concentrates with a CoA showing strength and its basis (% w/v, % w/w or % v/v), lot number and expiry.
  • Water of the grade fixed by your site for disinfectant preparation (for example purified water). The earlier version used both “DM water” and “distilled water”; pick one grade and write it down.
  • Calibrated measuring cylinders and a calibrated balance (for phenol).
  • Pre-cleaned containers of a compatible material; sterilised containers where the solution will be used in Grade A or B areas.
  • For Grade A and B use: a sterile 0.22 µm filter assembly compatible with the solution, or a qualified sterile ready-to-use product.
  • Personal protective equipment as stated on each disinfectant’s safety data sheet: gloves, goggles, mask and apron.

Procedure for Preparation of Sanitizing Solution

Sanitizing solution in pharma preparation flow: check stock CoA, calculate V1 = C2 x V2 / C1, dilute, sterile-filter for Grade A and B, label and record, use within the in-use period Sanitizing solution in pharma: preparation flow Six steps: check the stock CoA strength, calculate the stock volume with V1 equals C2 times V2 divided by C1, dilute in a pre-cleaned container, sterile filter for Grade A and B areas, label with a use-by time, use within the validated period and discard. The programme uses more than one type of disinfectant plus a periodic sporicidal agent, confirmed by environmental monitoring. Sanitizing solution in pharma: preparation flow Revised Schedule M Part II cl. 3.1–3.3 · EU GMP Annex 1 cl. 4.33–4.35 1 Check the stock CoA strength, lot and expiry Note the basis: % w/v, w/w or v/v 2 Calculate V1 = C2 × V2 ÷ C1 Second person checks the calculation 3 Dilute Pre-cleaned, labelled container Site-defined water; make up to volume 4 Grade A / B area? Yes: sterile before use (0.22 µm filtration or qualified sterile RTU) 5 Label and record Strength, prepared and use-by time 6 Use, then discard Within the validated in-use period Programme: more than one type of disinfectant + a periodic sporicidal agent Effectiveness confirmed by environmental monitoring · laafon.com
Six-step preparation flow. Steps 4 and 6 are the ones auditors check first: sterility before use in Grade A and B, and a use-by time on every container.

5. Procedure

5.1

Prepare solutions only in the disinfectant preparation area defined by your site. (The earlier version named “the third airlock”; the location is a site decision, not a requirement.) Wear the PPE listed on the safety data sheet.

5.2

Check the concentrate: name, lot number, expiry date, and strength with its basis from the CoA. Do not use a concentrate that is expired or whose strength is not known.

5.3

Calculate the volume of concentrate: V1 = C2 × V2 ÷ C1, where C1 is the stock strength, C2 the target strength (same basis) and V2 the final volume. Record the calculation. A second person checks it before preparation starts.

5.4

Take a pre-cleaned container (sterilised where step 5.8 applies). Label it before filling so an unlabelled container never holds a solution.

5.5

Add about half the final volume of water, then the measured concentrate, then make up to the final volume with water and mix. For v/v solutions such as alcohol, always make up to volume; do not add two volumes together.

5.6

Prepare each solution as below (per 1,000 mL final volume, using the example stock strengths; recalculate for your CoA value):

5.6.1 Isopropyl alcohol 70 % v/v. 707 mL of 99 % v/v IPA made up to 1,000 mL with water. (700 mL is correct only if the stock is treated as 100 %.)

5.6.2 Hydrogen peroxide 4 % w/v. 133 mL of 30 % w/v peroxide made up to 1,000 mL. From a 6 % w/v stock the same target needs 667 mL.

5.6.3 Benzalkonium chloride 2 % w/v. 40 mL of a 50 % w/v concentrate made up to 1,000 mL.

5.6.4 Glutaraldehyde 2 % w/v, activated. 80 mL of 25 % w/v (or 40 mL of 50 % w/v) made up to 1,000 mL, then activate with the supplier’s activator to pH 7.5 to 8.5 and record the pH and the activation date.

5.6.5 Phenol 5 % w/v. Weigh 50 g of phenol (melt the container in a water bath only to make it pourable), dissolve and make up to 1,000 mL.

5.6.6 Savlon 2 % v/v and 5.6.7 Dettol 2 % v/v. 20 mL of the branded product made up to 1,000 mL. These percentages are of the product as supplied, not of its active ingredient; follow the label and your efficacy data.

5.7

Target strengths in 5.6 are those carried by the earlier version of this SOP. They are site choices, not compendial values. Confirm each against your disinfectant efficacy validation before adopting this SOP.

5.8

Grade A and B areas: the solution must be sterile before use. Filter it through a sterile 0.22 µm filter into a sterile container under controlled conditions, or use a qualified sterile ready-to-use product backed by a certificate of analysis or conformance.

5.9

Label the container (Annexure-III): solution name and strength, stock lot, date and time of preparation, use-by date and time, prepared by and checked by.

5.10

Record the preparation in Annexure-I.

5.11

Use the solution within its validated in-use period. Do not top up a part-used container with fresh solution. Discard any solution past its use-by time, then return the container for cleaning.

5.12

Apply solutions according to the disinfection SOP and the schedule in Annexure-II, which must include more than one type of disinfectant and a sporicidal agent.

Preparation of Disinfectant Solution: Dilution Table by Stock Strength

This table puts the calculation in one place. The example stock strengths are common supply strengths, not a recommendation; your CoA value replaces them. The last column shows what the earlier version of this SOP would have produced.

SolutionTarget strengthExample stockStock per 1,000 mLSpectrum note (class data, CDC)Earlier version gave
Isopropyl alcohol70 % v/v99 % v/v707 mLEffective at 60 to 90 % v/v in water; does not destroy bacterial spores [5]700 mL: correct if stock taken as 100 %
Hydrogen peroxide4 % w/v30 % w/v133 mLSporicidal only at a validated concentration and contact time [5]40 mL: gives 1.2 % w/v
Hydrogen peroxide4 % w/v6 % w/v667 mLAs above40 mL: gives 0.24 % w/v
Benzalkonium chloride2 % w/v50 % w/v40 mLQuaternary ammonium: not sporicidal [5]20 mL: gives 1 % w/v
Glutaraldehyde (activated)2 % w/v25 % w/v80 mLSporicidal only after activation to pH 7.5 to 8.5 [5]“Glyceraldehyde” 20 mL: 0.5 % if 25 % stock
Glutaraldehyde (activated)2 % w/v50 % w/v40 mLAs above20 mL: gives 1 % w/v
Phenol5 % w/vPhenol, solid50 gPhenolic: not sporicidal [5]50 mL melted: slightly above 5 %
Savlon (chlorhexidine + cetrimide)2 % v/v of productProduct as supplied20 mLCetrimide is a quaternary ammonium compound: not sporicidal [5]20 mL: consistent
Dettol (chloroxylenol)2 % v/v of productProduct as supplied20 mLChloroxylenol is a phenolic: not sporicidal [5]20 mL: consistent

Swipe the table sideways on a phone. “Not sporicidal” refers to the chemical class as recorded by CDC; a specific branded formulation may carry its own claim, which your efficacy study must confirm.

Worked example: 5 litres of 4 % hydrogen peroxide

Stock on the CoA: 30 % w/v. Target: 4 % w/v. Final volume: 5,000 mL.

V1 = 4 × 5,000 ÷ 30 = 666.7 mL

Measure 667 mL of the 30 % stock into about 2.5 L of water and make up to 5,000 mL. If the CoA states the strength as % w/w, convert it to w/v first by multiplying by the solution’s density from the CoA or safety data sheet (for 30 % w/w peroxide this is roughly 1.11 g/mL, giving about 33 % w/v). Mixing bases is the other easy calculation error to make, after leaving the stock strength out altogether.

Sanitizing Solution in Pharma: What Schedule M, Annex 1 and FDA Require

Three documents govern how a sanitizing solution in pharma manufacturing is prepared and used in a sterile plant serving India and export markets. They agree more than most SOPs suggest, and none of them contains several of the “requirements” Indian SOPs routinely attribute to them.

RequirementRevised Schedule M, Part II (sterile) [1]EU GMP Annex 1 (2022) [2]US FDA aseptic guidance (2004) [3]
Written programme3.1: approved written programme4.33: written programmeX.A.3: procedures detailed enough to reproduce (preparation, sequence, contact time)
More than one disinfectant3.1: “more than one type shall be employed”4.33: more than one type, with different modes of actionNot stated in these words
Sporicidal agent3.3: programme shall include a sporicidal agent4.33: periodic use of a sporicidal agentX.A.3: on a written schedule and when monitoring suggests spore-formers
Sterile before use3.2: in Grade A and B areas4.35: in Grade A and B; Grade C and D where the contamination control strategy requiresX.A.3: disinfectants should be sterile
Storage of dilutions3.2: previously cleaned containers; defined periods unless sterilised4.35: previously cleaned (sterilised where applicable) containers; defined periodX.A.3: suitable (e.g. sterile) containers; no longer than the predefined period
Microbial monitoring of disinfectants3.2: disinfectants and detergents shall be monitored4.35: when diluted or prepared in-houseNot stated in these words
Efficacy and residues3.1 and 3.3: effectiveness demonstrated; residues detected and removed by cleaning4.33 and 4.34: validated on the surfaces used; supports in-use expiry; residues removedX.A.3: suitability, efficacy and limitations assessed
The word “rotation”Not used for disinfectantsNot usedNot used
A named agent or a hold-time numberNoneNoneOnly 70 % IPA, named as ineffective against Bacillus spores

Clause numbers checked by full-text search of each document in October 2026. “Not used” means the string does not occur anywhere in the document.

Disinfectant rotation is industry vocabulary, not regulatory text. A character search of the notified Schedule M, of Annex 1 and of the FDA guidance found the word “rotation” only in stock-rotation and machinery contexts in Schedule M, and not at all in the other two. What the regulators actually require is narrower and easier to defend at inspection: more than one type of disinfectant, a sporicidal agent used periodically, and evidence from environmental monitoring that the programme works. An SOP that alternates two quaternary ammonium products month by month “rotates” but still has no sporicide, and fails both Schedule M 3.3 and Annex 1 4.33.

For oral solid and liquid plants (Schedule M Part I), the obligations are lighter but still written. Clause 4 puts “products for cleaning and disinfection” inside the scope of the sanitation programme, clause 11.5.2 requires personnel to wash and sanitise their hands before entering production, and clause 16.5 states that sanitising materials shall not contaminate equipment, materials or products. The US equivalent is 21 CFR 211.56(c), which requires written procedures for the use of cleaning and sanitizing agents [4]. Revised Schedule M is now in its enforcement phase: the extended date for eligible small and medium manufacturers that applied was 31 December 2025 [6], and CDSCO asked state regulators to begin inspections in November 2025 [7].

Acceptance Criteria and Frequency

Badges show where each criterion comes from. regulatory means a requirement in the cited document; site policy means your QMS sets the value; check source means a figure exists in a paywalled standard that could not be read for this page, so no number is published here.

CheckCriterionBasis
ConcentrateWithin expiry; CoA strength and basis recordedsite policy good documentation practice
CalculationV1 = C2 × V2 ÷ C1 recorded and checked by a second personsite policy
Alcohol strengthTarget 70 % v/v; the effective range is 60 to 90 % v/v in waterCDC effective range, not a compendial limit [5]
Glutaraldehyde activationpH 7.5 to 8.5 after activation; used within the activated shelf life on the label (CDC: at least 14 days)CDC plus supplier label [5]
Sterility (Grade A and B)Sterile before use: filtered through a sterile 0.22 µm filter with integrity confirmed, or qualified sterile ready-to-use product with CoAregulatory Schedule M Part II 3.2; Annex 1 4.35 [1,2]
Microbial quality of in-house dilutionsMonitored at a defined frequency; limits set by QAregulatory duty to monitor (Schedule M 3.2) site policy limit
In-use periodValidated period; discard at expiry; no topping upregulatory Annex 1 4.34 and 4.35; Schedule M 3.2 site policy the number of hours or days
Disinfectant efficacyLog reduction against facility isolates on representative surfaces, by a validated methodcheck source USP general chapter on disinfectants and antiseptics, or the EN surface-test standard your site follows

Frequency

ActivityFrequencyBasis
Preparation of each dilutionFresh for each validated in-use periodsite policy
Sporicidal agentOn a written schedule, plus whenever monitoring recovers spore-formersregulatory FDA X.A.3; Annex 1 4.33 says “periodic” [2,3]
Microbial monitoring of dilutionsDefined by QA (for example, per new concentrate lot and periodically)site policy
Efficacy revalidationOn any change of agent, supplier, surface material or contact timeregulatory validation duty in Annex 1 4.34 site policy trigger list
SOP reviewAs per your document control proceduresite policy

Precautions

For the person preparing the solution

  • Wear the gloves, goggles, mask and apron the safety data sheet specifies before opening any concentrate.
  • Isopropyl alcohol is flammable: prepare it away from ignition sources, in a ventilated area, and keep only the volume needed.
  • Phenol and glutaraldehyde are hazardous chemicals: follow the safety data sheet for each, including any requirement for local exhaust ventilation.
  • Never mix two disinfectants in one container, and never pour a solution back into the concentrate container.

The ones that fail an audit

  • A container with no use-by time, or a solution in use past it.
  • A dilution written as “X mL to 1 litre” with no stock strength anywhere in the SOP or the record.
  • Non-sterile alcohol or disinfectant carried into a Grade A or B area.
  • A disinfectant list with no sporicidal agent, or two agents of the same chemical class.
  • Part-used containers topped up with fresh solution, which resets the label but not the contamination.

Deviation Handling

EventImmediate actionFollow-up
Wrong strength prepared, found before useDiscard; prepare again; recordRetrain; review the calculation check
Wrong strength or expired solution already usedRaise a deviation; re-disinfect the affected area with a correct solutionImpact assessment on batches and environmental monitoring results for the period
Microbial growth found in a prepared dilutionQuarantine the remaining solution and the concentrate lotInvestigate the water, the container cleaning and the concentrate; review EM data from areas where it was used
Filter integrity test failure (Grade A and B solution)Do not use; re-filter through a new tested filter or discardInvestigate the filter and the procedure
Environmental monitoring excursion after disinfectionFollow the OOS procedure for environmental monitoringIdentify the isolate; test its sensitivity to the agents in use; consider the sporicide schedule

Annexures and Record Formats

Annexure-I: Disinfectant Solution Preparation Record

DateTimeSolution and target strengthConcentrate, lot, CoA strengthStock volume (mL)Final volume (mL)Water gradeFiltered? Filter IDUse-by date and timePrepared byChecked by

Annexure-II: Disinfectant Schedule by Area Grade

AreaGradeDisinfectant A (days)Disinfectant B, different class (days)Sporicidal agent (frequency)Sterile before use?
A / BYes (Schedule M Part II 3.2)
C / DWhere your contamination control strategy requires
Non-classifiedSite policy

Annexure-III: Container Label

Solution and strengthConcentrate lot
Prepared on (date, time)Use before (date, time)
Sterile-filteredYes / NoPrepared by / Checked by

Revision history

VersionEffective dateChange
00DD-MMM-YYYYNew SOP
01DD-MMM-YYYYStock-strength calculation added; benzalkonium, peroxide and glutaraldehyde volumes corrected; Grade A and B sterility, labelling, in-use period and sporicide added

FAQ

Getting a sterile area ready for a Revised Schedule M inspection?

Disinfection sits in Part II of Revised Schedule M, and state inspections against it are under way. Laafon’s live Schedule M dashboard tracks enforcement status, key dates and the major changes, and links to paid consultation if you want your disinfection programme reviewed against the clauses above.

Open the Schedule M compliance dashboard

References

  1. Ministry of Health and Family Welfare (India). Drugs Rules, 1945: Schedule M, Good Manufacturing Practices and Requirements of Premises, Plant and Equipment for Pharmaceutical Products (revised), G.S.R. 922(E). Gazette of India, Extraordinary; 28 Dec 2023. Part I clauses 4, 11.5.2 and 16.5; Part II clauses 3.1 to 3.4. Gazette reprint available from: pharmadocx.com; notification summary: Drugs Control Department, Puducherry. Accessed Oct 2026.
  2. European Commission. EudraLex Volume 4, Annex 1: Manufacture of Sterile Medicinal Products. C(2022) 5938 final; 22 Aug 2022, in operation from 25 Aug 2023. Clauses 4.33 to 4.36. Available from: health.ec.europa.eu. Accessed Oct 2026.
  3. US Food and Drug Administration. Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing, Current Good Manufacturing Practice. Sep 2004. Section X.A.3, Disinfection Efficacy. Available from: fda.gov. Accessed Oct 2026.
  4. Code of Federal Regulations. 21 CFR 211.56, Sanitation. Available from: ecfr.gov. Accessed Oct 2026.
  5. Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee. Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008: Chemical Disinfectants. Centers for Disease Control and Prevention. Available from: cdc.gov. Accessed Oct 2026.
  6. Business Standard. MSME pharma units get breather as govt extends Schedule M deadline. 4 Jan 2025. Available from: business-standard.com. Accessed Oct 2026.
  7. Business Standard. CDSCO asks state units to start inspections under Schedule M norms. Nov 2025. Available from: business-standard.com. Accessed Oct 2026.

This procedure is a template for adaptation. It requires local qualification, validation and Quality Assurance approval before use, and every target strength, in-use period and acceptance criterion must be confirmed by your own disinfectant efficacy data and checked against the current edition of the applicable regulations. Pharmacopoeial texts and Indian statutory instruments change between editions. Branded products are named only because the earlier version of this SOP named them; follow each manufacturer’s label. Technical and educational content only, not medical, legal or investment advice.

Darshan Singh
Darshan Singh

Author is a pharmaceutical quality and regulatory professional with more than 23 years in drug manufacturing. He holds an M.Sc. in Organic Chemistry and a Diploma in Pharmacy. He has served as Quality Control Head, Quality Assurance Head and Plant Head, overseeing all manufacturing operations. He is co-founder and regulatory consultant at Laafon Galaxy Pharmaceuticals. He writes on SOPs, manufacturing processes, Schedule M compliance and drug pharmacology, and checks each claim against pharmacopoeial and regulatory sources.

Articles: 233